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Abstract
Copper is an essential trace element. However, excess copper can lead to oxidation of biomolecules and cell
damage and copper levels must be carefully controlled. While copper homeostasis has been studied
extensively at the cellular level, short-term body copper ﬂuxes are poorly understood. Here, we assessed for
the ﬁrst time the feasibility of measuring whole body copper ﬂux by positron emission tomography, using
64Cu. A comparative approach comparing the Long–Evans cinnamon (LEC) rat to the wild type was
chosen. LEC rats are an accepted model for Wilson disease, an inherited disorder of copper excretion in
humans. In LEC rats as well as in Wilson patients, the copper transporting ATPase, ATP7B, is defective.
This ATPase is primarily expressed in the liver and serves in copper secretion via the bile. Dysfunction of
ATP7B leads to accumulation of copper in the liver. A control and an LEC rat were transgastrically
injected with 10 lg of 64Cu and the copper ﬂux followed for three hours by whole animal PET and
concomitant collection of bile, as well as the analysis of tissue following tomography. As seen by PET, the
administered copper was largely trapped in the stomach and the proximal intestine, and without a sig-
niﬁcant diﬀerence between control and LEC rat. Due to an insuﬃcient dynamic range of the PET tech-
nology, copper which was systemically absorbed and primarily transported to the liver could only be
followed by sampling and by b-counting. Biliary copper excretion ensued after 15 min in the control rat,
but was absent in the LEC rat. Biliary excretion reached saturation one hour after copper administration.
The trapping of orally administered copper in the gastrointestinal tract may be an important mechanism to
prevent copper toxicity under conditions of a sudden, excessive copper load, which cannot be alleviated by
increased biliary secretion. This trapping does however limit the utility of PET to measure whole animal
copper ﬂux.
Introduction
Copper is an essential trace element. In living
organisms, it serves as a cofactor for many enzymes
due to its biologically suitable redox potential.
However, copper excess can lead to random
oxidation of biomolecules and thus causes toxic
eﬀects. Cellular copper level is therefore tightly
controlled in all organisms. Recent work on the
mechanism of copper homeostasis has given great
insight into themechanismof copper homeostasis at
the cellular level. Key elements of copper ﬂux in
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mammalian cells are two ATPases for copper
transport into the trans-Golgi network and secre-
tion into the bile, respectively, a plasma membrane
copper transporter, and a number of copper chap-
erones which serve in the delivery of copper to
speciﬁc cuproenzymes (see Andrews 2002; Luk
et al. 2003; Lutsenko et al. 2003;Mercer et al. 2003;
Thiele 2003; Prohaska & Gybina 2004 for recent
reviews).
In contrast to the detailed understanding of
copper transport at the cellular level, very little is
known about the short-term dynamics of copper
ﬂuxes at the level of the whole organism. Positron
emission tomography (PET) oﬀers a new tool to
look at the distribution of 64Cu in real-time in a
living animal. The feasibility of using this tech-
nique was assessed here by following the fate of
orally administered 64Cu in rats over a period of
3 h. For greater study-depth, normal and Long–
Evans Cinnamon (LEC) rats were compared. The
LEC rat is an accepted animal model of human
Wilson disease, which leads to copper accumula-
tion, primarily in the liver, due to impaired copper
excretion via the bile. Molecular studies have re-
vealed that in both, LEC rats and Wilson patients,
the copper transporting P-type ATPase, ATP7B, is
defective (Petrukhin et al. 1993; Tanzi et al. 1993;
Wu et al. 1994; Shah et al. 1997; Forbes & Cox
1998; Ferenci et al. 2003). The ATPase belongs to
the highly conserved family of CPx-type ATPases
which translocate toxic as well as essential heavy
metal ions across biological membranes (Lutsenko
& Kaplan 1995; Solioz & Vulpe 1996).
When the radioisotope 64Cu decays, a posi-
tron is emitted, which can be detected by PET.
This technique has recently advanced to a state
allowing the imaging of small animals with high
resolution. In the present study, we applied
PET to assess whole body ﬂuxes of 64Cu in a
control and LEC rat. The study showed the
feasibility of imaging 64Cu in whole rats.
However, the limited dynamic range of PET
proved to be a major limitation. It was found
that a bolus of orally administered copper was
poorly resorbed. At the same time, biliary
copper secretion was readily saturated. This
suggests a mechanism for preventing copper
toxicity by limiting intestinal absorption under a
high copper load. This could explain the high
copper tolerance of rats.
Materials and methods
Animals
The female LEC rat was obtained from Charles
River, Japan, and the control female Wistar rat
from Deutsche Versuchstierfarm, Tuttlingen,
Germany. Rats were kept under a 14-h light and
10-h dark cycle and on a standard diet with
15 ppm of copper (Provimi-Kliba AG, Kai-
seraugst, Switzerland), along with tap water ad
libitum. Prior to experiments, rats were starved for
12 h.
Animal experiments
Animal experiments were performed under pen-
tobarbital anesthesia (50 mg/kg, intraperitone-
ally). Right after animals had been anaesthetized,
an abdominal incision was made in order to ac-
cess the abdominal cavity. Bile ﬂow was mea-
sured by cannulation of the bile duct with a
polyethylene tube (PP-10, Laubscher AG, Ho¨l-
stein, Switzerland) and external drainage and
fractionation with a fraction collector. Ten lg
Cu2+ (applied as a CuSO4 solution) with a
speciﬁc c-activity of 17.3 MBq/lg copper
(15.13 MBq of 64Cu and 2.19 MBq of 67Cu) was
introduced into the stomach by transgastric
injection. Immediately after injection, the
abdominal incision was adapted and the PET
analysis was started. At the end of experiments
(180 min after start of PET analysis) the animals
were exsanguinated. Liver, brain and spleen were
harvested for weighing and b-counting. All ani-
mal experiments were performed in compliance
with Swiss laws and regulations and had been
approved by a State Committee on Ethics in
Animal Experimentation.
Production of radioactive copper
64,67Cu was produced by irradiating natZn-target
with protons at the 72 MeV accelerator and fol-
lowing separation from the target material as de-
scribed (Schwarzbach et al. 1995). For 64Cu
production the proton irradiation schedule was re-
duced to maximally 20 h and the Zn-target was
processed 12 hpost endof bombardment (EOB).At
this time the ratio of 64Cu/67Cu was 20/1.
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PET-analysis
PET experiments were performed with the 16-
module variant of the quad-HIDAC tomograph
(Oxford Positron Systems, Weston-on-the-Green,
UK). The camera had four detector banks each
comprising four HIDAC (high density avalanche
chamber) modules. Each module consists of a
multi-wire proportional chamber between lead
layers containing a matrix of holes of 0.4 mm in
diameter and 0.5 mm pitch. The ﬁeld of view is
280 mm axially and 170 mm in diameter allowing
the acquisition of whole body images in a single
bed position. Anesthetized animals were ﬁxed with
adhesive tape and positioned in the camera such
that the whole body was placed symmetrically in
the center of the ﬁeld of view. Body temperature
was controlled by a rectal probe and kept at
37.3 C by a thermocoupler and a heated air
stream. Acquisition of PET data was initiated
right after application of the radiotracer and lasted
for 3 h. PET data were acquired in list-mode and
reconstructed using the OPL-EM algorithm
(Reader et al. 1998) with a bin size of 0.5 mm, a
matrix size of 200 · 200 · 500, and resolution
recovery with width 1.3 mm. Reconstruction did
not include scatter, random, attenuation and de-
cay correction. Seven time frames were recon-
structed: 0–15, 15–30 30–45 45–60 60–90 90–120
120–180 min. The volumetric image ﬁles of the
ﬁrst and last time frame were represented in three
dimensions using the software VGStudio Max 1.1
(Volume Graphics GmbH, Heidelberg, Germany).
Native blue gel electrophoresis
Native blue gel electrophoresis on 6–16% linear
polyacrylamide gradients was conducted and the
migration position of serum proteins identiﬁed
as described (Schagger & von Jagow 1991; Mura-
tsubaki et al. 2002). Gels were dried and radioac-
tivity was measured on a PhosphoImager (Storm
840; Molecular Dynamics, Sunnyvale, USA).
Results
The female LEC rat was 15 weeks old at the time of
experiments. The control had the same age, but was
bigger with a corresponding diﬀerences in organ
weights (cf. Table 1) The animals were anesthetized
and a bolus of 10 lg of radioactive copper was
administered as described under Material and
methods. This was followed immediately by PET
scans with 15 min time windows (0–15, 15–30,
30–45, 45–60, 60–75, 75–90, 90–105, 105–120,
120–135, 135–150, 150–165, 165–180 min). After
180 min, the animals were sacriﬁced by exsangui-
nation and the spleen, the brain and the liver were
harvested for b-counting. The liver was in addition
examined by histology. The liver of the LEC rat had
no signs of acute hepatitis with sub-massive
necrosis, which can occur at this age (Terada &
Sugiyama 1999). No major ﬁbrosis could be
observed in either liver (data not shown).
PET data were acquired for 180 min and recon-
structed in 15 min time frames. Two-dimensionally
reconstructed pictures of the PET scans of the time
frames from 0 to 15 min and from 165 to 180 min
after copper administration are shown for control










Body 459 1 · 104 148 1 · 104
Liver 13.9 27.7 4.71 59.4
Brain 2.02 0.05 1.56 0.15
Spleen 0.8 0.17 0.25 1.43
aCopper supplied to the animal.
Figure 1. Reconstructed pictures of whole body PET. The
three-dimensional PET scans were reconstructed to two-
dimensional images. Shown are the time frames from 0 to
15 min and from 165–180 min after copper administration for a
control rat and an LEC rat. The bar corresponds to 1 cm and
the resolution is 0.5 mm. Movies of these PET scans can be
found at www.ikp.unibe.ch/pet.
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and LEC rats in Figure 1. The shapes of the
signals demarcate the silhouette of the stomach
and the upper part of the intestine. The scans
conﬁrm on one hand the correct application of the
radioactive copper and on the other hand show
transport of copper out of the stomach into the
intestine during the observation period. Movies of
PET scans taken at the beginning and the end of
the experiments are available on the Internet at
http://www.ikp.unibe.ch/pet/.
The fraction of 64Cu which was systemically
absorbed could not be detected by the PET
instrument due to the large background signal of
the copper remaining in stomach and intestine.
Radiocopper in bile, collected during the experi-
ment, and in tissue was measured post mortem by
b-counting (Table 1, Figure 2). Compared to the
control, the LEC rat accumulated approximately
twice as much copper in the liver, three times as
much in the brain and eight times as much in the
spleen. Since the organs of the LEC rat were
smaller than in the control animal, the relative
copper accumulation was even higher. In both
animals, the highest amount of the systemically
distributed copper was found in the liver.
In the control rat, copper excretion by the bile
could be measured 15 min after the application of
copper into the stomach. After an hour, a plateau
phase was reached, with an intriguing sinusoidal
ﬂuctuation about the plateau value (Figure 2). As
expected, in the LEC rat there was no measurable
copper excretion, since the copper secreting
ATPase, ATP7B, is defective in these animals.
To identify serum proteins which would pri-
marily become copper loaded, non-denaturing,
native blue gel electrophoresis of the serum was
performed (Schagger & von Jagow 1991). In this
gel electrophoretic method, the proteins are not
denatured and should thus retain bound copper.
Figure 3 shows that the major copper binding
protein was albumin. The autoradiography of
Figure 3 suggests that other proteins of lower and
higher molecular weight than albumin also bound
copper, but their identity is not clear.
Discussion
Little is known about the intestinal absorption of
copper. Bronner et al. examined the absorption of
64Cu in the mouse duodenum by counting the
radioactivity of the intestine at certain time points
(up to 180 min) (Bronner & Yost 1985). They
showed that within 60–120 min between 85 and
90% of the total copper was absorbed. Unfortu-
ately, absorption in the stomach was not evalu-
ated. Studies of the 60s showed that the small
intestine as well as the stomach show a mucosal
















Figure 2. Copper excretion in bile. Fractions of 5 min were
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Figure 3. Native gel electrophoresis of serum proteins. Whole
serum was separated on native gels, followed by staining with
Coomassie blue (a) and autoradiography (b). Lane 1, 0.5 lg of
bovine serum albumin; lane 2, 0.5 ll of serum from control rat,
lane 3, 0.5 ll serum of LEC rat. Serum samples were taken 3 h
after injection of 64Cu. The arrows indicate the migration
positions of ceruloplasmin (CP), transferrin (TF), and albumin
(A). Further details are described under Methods.
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1965; Marceau et al. 1970). However, mucosal
uptake is not equivalent to systemic uptake. How
much of intestinally absorbed copper actually
reaches the circulation has not been suﬃciently
investigated so far.
We here investigated the possibility of using
PET to measure copper ﬂuxes in the whole ani-
mal. A major limitation to the technique proofed
to be the extent of the dynamic range: weak
signals of systemically absorbed copper could not
be processed in the presence of the much stronger
signal of the applied copper dose. Nevertheless,
some insight could be gained. Our data show that
a copper challenge resulted in trapping of copper
in stomach and intestine. This was not aﬀected
by the diﬀerent total body copper levels in the
control and the LEC rat. Whether this trapped
copper eventually enters the systemic copper pool
is not clear. With the high turn over of mucosal
and intestinal cells, trapped copper could get
excreted by the natural cell sloughing. This could
be a mechanism of protection from copper tox-
icity under acute conditions. In fact, the mecha-
nism of copper secretion via the loss of intestinal
cells is taken advantage of in one type of therapy
for Wilson disease patients: orally administered
zinc induces the synthesis of the heavy-metal
binding protein metallothionein in enterocytes
(Brewer 1995; Brewer et al. 1998). This pool of
metallothionein in turn traps copper, thus low-
ering the system copper load in these patients.
The copper trapped by the enterocytes leaves the
organism via the stool by the normal sloughing
oﬀ of cells.
As determined by post-mortem b-counting, a
small fraction of copper was further distributed in
the body. In the LEC rat, copper accumulation in
the organs analyzed was several fold greater than
in the control (Table 1). There was much more
copper in the liver than in the spleen, which is one
of the bloodiest organs. Hence, the copper was in
the parenchymal cells and did not merely represent
the amount of blood in the organ. Biliary copper
excretion started 15 min after the administration
of copper and plateaued at 1 h in the control rat.
A similar onset of biliary excretion has been ob-
served for the clearing of intravenously injected
copper (Harada et al. 1993).
In the LEC rat, biliary secretion remained at
background level, corroborating the key function
of ATP7B in copper excretion into the bile.
However, a major contribution to the prevention
of systemic over-absorption of excess copper seems
to be accomplished by trapping of copper in the
stomach and the intestine. Even if this trapped
copper gets slowly absorbed over days, this ‘stor-
age’ protects the organism from toxic serum levels
that could not be managed by ATP7B. Further
studies over longer observation periods would be
needed to clarify the fate of the trapped copper.
This is, however, not easily feasible with PET
scanning as the animals have to be anesthetized
during the observation period.
Taken together, our data suggest that copper
trapping in the stomach and intestine may be an
important mechanism to prevent toxic copper
accumulation under conditions of excess copper
intake. Assessing whole body copper ﬂux by PET
is limited by the dynamic range of current instru-
mentation, but is potentially useful in combination
with other measurements.
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